| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.980 | 2 | 0 | 1995 | 2019 | ||||||||
|
insulin like growth factor 2 receptor | 0.518 | 0.731 | 1.00 |
|
disease | 0.700 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.400 | None | 0.955 | 1 | 0 | 1995 | 2020 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.400 | None | 0.769 | 1 | 0 | 1995 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.400 | None | 0.879 | 1 | 0 | 1995 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.857 | 1 | 0 | 1995 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 1995 | 2020 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.400 | None | 0.917 | 1 | 0 | 1995 | 2018 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.400 | None | 0.941 | 2 | 0 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.984 | 2 | 0 | 1996 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.400 | None | 0.964 | 1 | 0 | 1996 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.400 | None | 0.963 | 1 | 0 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1996 | 2020 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.390 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
vasoactive intestinal peptide receptor 1 | 0.573 | 0.654 | 7.4E-27 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
disease | 0.390 | None | 0.900 | 1 | 0 | 1996 | 2017 | ||||||||
|
carbonic anhydrase 2 | 0.506 | 0.808 | 1.7E-06 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.984 | 2 | 0 | 1997 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 0.972 | 2 | 0 | 1997 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.400 | None | 0.923 | 2 | 0 | 1997 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 3 | 0.514 | 0.769 | 1.9E-03 |
|
disease | 0.590 | None | 0.900 | 1 | 0 | 1997 | 2017 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.400 | None | 0.972 | 1 | 0 | 1997 | 2020 | ||||||||
|
BMP binding endothelial regulator | 0.641 | 0.577 | 6.6E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1997 | 2017 |